China Under Pressure to Reveal Vaccine Data After Pfizer Success
- None of China’s vaccine frontrunners have released key data
- Difficult for China’s adversaries to trust its vaccine trials
This article is for subscribers only.
Western politicians have faulted China for initial delays in providing information as the coronavirus spread around the world. Now as Beijing develops a vaccine, the need for transparency is proving essential to win back trust.
American drugmaker Pfizer Inc. and German biotechnology firm BioNTech SE announced this week that its vaccine appears more than 90% effective in stopping Covid-19 infections. The preliminary finding spurred a global stock rally and put the companies at the head of the pack in the race for the vaccine.